threonine has been researched along with Lupus Erythematosus, Systemic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lu, LD; Ruggeri, BA; Seavey, MM; Stump, KL; Wallace, NH | 1 |
VOLKOV, VP | 1 |
Honda, H; Honda, Z; Kono, H; Kyogoku, C; Suzuki, T; Tokunaga, K; Tsuchiya, N; Yamamoto, K | 1 |
3 other study(ies) available for threonine and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE.
Topics: Animals; Antibodies, Antinuclear; Boronic Acids; Cytokines; Disease Models, Animal; Drug Administration Routes; Female; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Spleen; Threonine | 2012 |
[FREE AMINO ACIDS IN THE BLOOD AND URINE OF PATIENTS WITH SOME FORMS OF DERMATOSIS].
Topics: Alanine; Amino Acids; Arginine; Aspartic Acid; Blood; Cystine; Dermatitis; Eczema; Erythema Multiforme; Glutamates; Glycine; Histidine; Lupus Erythematosus, Systemic; Lysine; Proteins; Psoriasis; Renal Aminoacidurias; Serine; Skin Diseases; Taurine; Threonine; Toxicology; Tryptophan; Urticaria | 1964 |
FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling.
Topics: Amino Acid Sequence; Amino Acid Substitution; Antigens, CD; B-Lymphocytes; Calcium Signaling; Cells, Cultured; Genetic Predisposition to Disease; Humans; Isoleucine; Lupus Erythematosus, Systemic; Membrane Microdomains; Molecular Sequence Data; Phosphatidylinositol Phosphates; Polymorphism, Genetic; Receptors, Antigen, B-Cell; Receptors, IgG; Signal Transduction; Threonine | 2005 |